Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of determining types I, II, III, IV or V or methicillin-resistant Staphylococcus aureus (MRSA) in a biological sample

Method of determining types I, II, III, IV or V or methicillin-resistant Staphylococcus aureus (MRSA) in a biological sample

US Patent 10041130 · Granted Aug 7, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Single nucleotide polymorphisms and community-associated methicillin-resistant S2020
Single nucleotide polymorphisms and community-associated methicillin-resistant S2020
Single nucleotide polymorphisms and community-associated methicillin-resistant S2019
Single nucleotide polymorphisms and community-associated methicillin-resistant S2019
Quantitation and profiling of vaginal microflora2018
Single nucleotide polymorphisms and community-associated methicillin-resistant S2017
Single nucleotide polymorphisms and community-associated methicillin-resistant S2017
Metronidazole resistance in trichomonas vaginalis and single nucleotide polymorp2017
Metronidazole resistance in trichomonas vaginalis and single nucleotide polymorp2017
Integrated method for collection and maintenance of detectability of a plurality2016
Integrated method for collection and maintenance of detectability of a plurality2016
Antibiotic resistance profile for Neisseria gonorrhoeae and use of same in diagn2016